Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosis

Archives of Dermatology

Volumn 134, Issue 10, 1998, Pages 1275-1278

  Helmbold, Peter ^a   Hegemann, Bernd ^a   Holzhausen, Hans Jürgen ^a   Klapperstück, Thomas ^a   Marsch, Wolfgang Ch ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETOPOSIDE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFICACY; HISTIOCYTOSIS X; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN ULCER;

ADMINISTRATION, ORAL; ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE;

EID: 0031733107     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.10.1275     Document Type: Article

References (23)

1. Chu AC. Histiocytoses. In: Champion RH, Burton JL, Ebling FJG, eds. Rook/Wilkinson/Ebling Textbook of Dermatology. 5th ed. London, England: Blackwell Scientific Publications; 1992;2041-2052.
2. Broadbent V, Pritchard J, Yeomans E. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X). Med Pediatr Oncol. 1989; 17:97-100.
3. Ishii E, Matsuzaki A, Okamura J, et al. Treatment of Langerhans cell histiocytosis in children with etoposide. Am J Clin Oncol. 1992;15:515-517.
4. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis: DAL HX-83 Study Group. Med Pediatr Oncol. 1994;23:72-80.
5. Yu LC, Shenoy S, Ward K, Warrier RP. Successful treatment of multisystem Langerhans cell histiocytosis (histiocytosis X) with etoposide. Am J Pediatr Hematol Oncol. 1994;16:275-277.
6. Ladisch S, Gadner H, Arico M, et al. LCH, I: a randomized trial of etoposide vs vinblastine in disseminated Langerhans cell histiocytosis: The Histiocyte Society. Med Pediatr Oncol. 1994;23:107-110.
7. Takemori H, Sakata Y, Suzuki H, et al. A case of malignant histiocytosis successfully treated with combination interferon and etoposide therapy. Jpn J Clin Oncol. 1990;20:431-435.
8. Santhosh-Kumar CR, Al Momen A, Ajarim DSS, Shipkey HF, Kyriacou KC. Unusual skin tumors in Langerhans cell histiocytosis. Arch Dermatol. 1990;126: 1617-1620.
9. Sheehan MP, Chu AC. Oral, skin and bone multisystem Langerhans cell histiocytosis and its response to etoposide: a case report. Clin Exp Dermatol. 1991; 16:463-466.
10. Mayou SC, Chu AC, Munro DD, Plowman N. Langerhans-cell histiocytosis: excellent response to etoposide. Clin Exp Dermatol. 1991;16:292-294.
11. Tsele E, Thomas DM, Chu AC. Treatment of adult Langerhans cell histiocytosis with etoposide. J Am Acad Dermatol. 1992;27:61-64.
12. Klapperstück T, Wohlrab W. DNA image cytometry on sections as compared with image cytometry on smears and flow cytometry in melanoma. Cytometry. 1996; 25:82-88.
13. Smith PJ, Soues S, Gottlieb T, et al. Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer. 1994;70:914-921.
14. McLeod HL, Evans WE. Clinical pharmacokinetics and pharmacodynamics of epipodophyllotoxins. Cancer Surv. 1993;17:253-268.
15. Greco FA. Future directions for etoposide therapy. Cancer. 1991;67(suppl):S315-S318.
16. Hande KR, Krozely MG, Greco FA, Hainsworth JD, Johnson DH. Bioavailability of low-dose oral etoposide. J Clin Oncol. 1993;11:374-377.
17. Thompson DS, Hainsworth JD, Hande KR, Holzmer MC, Greco FA. Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study. J Clin Oncol. 1993;11:1322-1328.
18. McLelland J, Newton JA, Malone M, Camplejohn RS, Chu AC. A flow cytometric study of Langerhans cell histiocytosis. Br J Dermatol. 1989;120:485-491.
19. Rabkin MS, Wittwer CT, Kjeldsberg CR, Piepkorn MW. Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis). Am J Pathol. 1988;131: 283-289.
20. Goldberg NS, Bauer K, Rosen ST, et al. Histiocytosis X: flow cytometric DNA-content and immunohistochemical and ultrastructural analysis. Arch Dermatol. 1986;122:446-450.
21. Rowinsky EK. Current developments in antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids. Curr Opin Oncol. 1991;3:1060-1069.
22. Soni N, Meropol NJ, Pendyala L, et al. Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer. J Clin Oncol. 1997;15:766-772.
23. Thomas L, Ducros B, Secchi T, Balme B, Moulin G. Successful treatment of adult's Langerhans cell histiocytosis with thalidomide. Arch Dermatol. 1993;129:1261-1264.